Business Context and Reporting Period
This Form 8-K was filed by Conversion Labs, Inc. (trading symbol: CVLB) on February 11, 2021. The report details the closing of a private placement offering of common stock. Note: The request metadata references "Lifemd, Inc.", but the filing text explicitly identifies the registrant as "Conversion Labs, Inc."
Key Financial Metrics
- Gross Proceeds: $14,000,008.00
- Net Proceeds: Approximately $13.4 million
- Shares Issued: 608,696 shares of Common Stock
- Purchase Price: $23.00 per share
- Placement Agent Fees: 3% of the Purchase Price paid to BTIG, LLC
Material Changes
The primary material change is the increase in cash liquidity resulting from the private placement. The company raised approximately $13.4 million in net proceeds, which will be available for general corporate purposes. No prior comparable period financial data (revenue, profit, or margins) is provided in this specific filing.
Guidance, Outlook, and Risks
Management Commentary: The company consummated the offering with accredited investors to raise capital. A press release was issued on February 12, 2021, to announce the transaction.
Registration Rights: The company entered into a Registration Rights Agreement requiring the filing of a Form S-1 registration statement within 60 business days of the closing date. The company must use reasonable best efforts to have the statement declared effective by the SEC within 120 days (or 150 days if subject to a full review).
Risks and Contingencies: The filing does not explicitly list new risks beyond the standard obligations of the registration process. The sale of shares was made in reliance on exemptions from registration requirements under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
Investor Verification Checklist
- Verify the exact number of shares issued (608,696) and the total dilution impact on existing shareholders.
- Confirm the timeline for the filing and effectiveness of the Form S-1 registration statement as required by the Registration Rights Agreement.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for any covenants or restrictions on the use of proceeds.
- Check subsequent filings to confirm the net proceeds were utilized as intended and to monitor the company's cash position.